Editorial: Insights in cardiovascular therapeutics: 2021 - cell death, cardiovascular injuries, and novel targets of cardiovascular therapeutics.
作者信息
Xu Keman, Khan Mohsin, Yu Jun, Snyder Nathaniel W, Wu Sheng, Vazquez-Padron Roberto I, Wang Hong, Yang Xiaofeng
机构信息
Departments of Cardiovascular Sciences and Biomedical Education and Data Sciences, Cardiovascular Research Center, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, United States.
Departments of Cardiovascular Sciences and Biomendical Education and Data Sciences, Centers for Metabolic Disease Research, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, United States.
出版信息
Front Cardiovasc Med. 2022 Jul 26;9:981544. doi: 10.3389/fcvm.2022.981544. eCollection 2022.
Abstract
摘要
相似文献
1
Editorial: Insights in cardiovascular therapeutics: 2021 - cell death, cardiovascular injuries, and novel targets of cardiovascular therapeutics.社论：心血管治疗领域的见解：2021年——细胞死亡、心血管损伤及心血管治疗的新靶点
Front Cardiovasc Med. 2022 Jul 26;9:981544. doi: 10.3389/fcvm.2022.981544. eCollection 2022.
2
Editorial: Highlights for Cardiovascular Therapeutics in 2021 - Trained Immunity, Immunometabolism, Gender Differences of Cardiovascular Diseases, and Novel Targets of Cardiovascular Therapeutics.社论：2021年心血管治疗领域亮点——训练免疫、免疫代谢、心血管疾病的性别差异以及心血管治疗的新靶点
Front Cardiovasc Med. 2022 Apr 27;9:892288. doi: 10.3389/fcvm.2022.892288. eCollection 2022.
3
Editorial: Insights in cardiovascular therapeutics 2022-cardiovascular innate immunity.社论：2022年心血管治疗新见解——心血管先天免疫
Front Cardiovasc Med. 2023 Apr 18;10:1184030. doi: 10.3389/fcvm.2023.1184030. eCollection 2023.
4
miRNA therapeutics in cardiovascular diseases: promises and problems.心血管疾病中的微小RNA治疗：前景与问题
Front Genet. 2015 Jun 30;6:232. doi: 10.3389/fgene.2015.00232. eCollection 2015.
5
Novel and Emerging Therapeutics for Primary Prevention of Cardiovascular Disease.新型和新兴治疗方法用于心血管疾病的一级预防。
Am J Med. 2019 Jan;132(1):16-24. doi: 10.1016/j.amjmed.2018.08.019. Epub 2018 Sep 7.
6
Editorial: Inflammation in Cardiovascular Diseases: Role of the Endothelium and Emerging Therapeutics.社论：心血管疾病中的炎症：内皮的作用及新兴疗法
Front Pharmacol. 2020 Nov 17;11:614387. doi: 10.3389/fphar.2020.614387. eCollection 2020.
7
Cell-Specific mRNA Therapeutics for Cardiovascular Diseases and Regeneration.用于心血管疾病和再生的细胞特异性mRNA疗法
J Cardiovasc Dev Dis. 2024 Jan 26;11(2):38. doi: 10.3390/jcdd11020038.
8
Cardiovascular complications of diabetes: recent insights in pathophysiology and therapeutics.糖尿病的心血管并发症：病理生理学与治疗学的最新见解
Expert Rev Endocrinol Metab. 2011 Sep;6(5):689-696. doi: 10.1586/eem.11.63.
9
Current RNA strategies in treating cardiovascular diseases.当前治疗心血管疾病的 RNA 策略。
Mol Ther. 2024 Mar 6;32(3):580-608. doi: 10.1016/j.ymthe.2024.01.028. Epub 2024 Jan 29.
10
RNA Therapeutics: the Next Generation of Drugs for Cardiovascular Diseases.RNA 疗法：心血管疾病的新一代药物。
Curr Atheroscler Rep. 2022 May;24(5):307-321. doi: 10.1007/s11883-022-01007-9. Epub 2022 Apr 2.
引用本文的文献
1
Caspase-11 promotes high-fat diet-induced NAFLD by increasing glycolysis, OXPHOS, and pyroptosis in macrophages.半胱氨酸天冬氨酸蛋白酶 11 通过增加巨噬细胞中的糖酵解、氧化磷酸化和细胞焦亡来促进高脂肪饮食诱导的非酒精性脂肪性肝病。
Front Immunol. 2023 Jan 26;14:1113883. doi: 10.3389/fimmu.2023.1113883. eCollection 2023.
本文引用的文献
1
Necroptosis in heart disease: Molecular mechanisms and therapeutic implications.心肌疾病中的细胞坏死性凋亡：分子机制与治疗意义。
J Mol Cell Cardiol. 2022 Aug;169:74-83. doi: 10.1016/j.yjmcc.2022.05.006. Epub 2022 May 18.
2
ZBP1-dependent inflammatory cell death, PANoptosis, and cytokine storm disrupt IFN therapeutic efficacy during coronavirus infection.ZBP1 依赖性炎症细胞死亡、PANoptosis 和细胞因子风暴破坏了冠状病毒感染期间 IFN 治疗的疗效。
Sci Immunol. 2022 Aug 26;7(74):eabo6294. doi: 10.1126/sciimmunol.abo6294.
3
Myocardial injury, troponin release, and cardiomyocyte death in brief ischemia, failure, and ventricular remodeling.短暂性缺血、衰竭和心室重构中的心肌损伤、肌钙蛋白释放和心肌细胞死亡。
Am J Physiol Heart Circ Physiol. 2022 Jul 1;323(1):H1-H15. doi: 10.1152/ajpheart.00093.2022. Epub 2022 May 13.
4
Z-DNA binding protein 1 promotes heatstroke-induced cell death.Z-DNA 结合蛋白 1 促进中暑诱导的细胞死亡。
Science. 2022 May 6;376(6593):609-615. doi: 10.1126/science.abg5251. Epub 2022 May 5.
5
Targeting regulated cell death (RCD) with small-molecule compounds in triple-negative breast cancer: a revisited perspective from molecular mechanisms to targeted therapies.用小分子化合物靶向三阴性乳腺癌中的调控细胞死亡（RCD）：从分子机制到靶向治疗的再思考视角。
J Hematol Oncol. 2022 Apr 12;15(1):44. doi: 10.1186/s13045-022-01260-0.
6
Monocyte Adhesion Assays for Detecting Endothelial Cell Activation in Vascular Inflammation and Atherosclerosis.用于检测血管炎症和动脉粥样硬化中内皮细胞活化的单核细胞黏附测定。
Methods Mol Biol. 2022;2419:169-182. doi: 10.1007/978-1-0716-1924-7_10.
7
Novel Knowledge-Based Transcriptomic Profiling of Lipid Lysophosphatidylinositol-Induced Endothelial Cell Activation.基于新知识的溶血磷脂酰肌醇诱导内皮细胞活化的转录组分析
Front Cardiovasc Med. 2021 Nov 29;8:773473. doi: 10.3389/fcvm.2021.773473. eCollection 2021.
8
The molecular mosaic of regulated cell death in the cardiovascular system.心血管系统中受调控的细胞死亡的分子镶嵌。
Biochim Biophys Acta Mol Basis Dis. 2022 Jan 1;1868(1):166297. doi: 10.1016/j.bbadis.2021.166297. Epub 2021 Oct 27.
9
Cardiac Troponins Metabolism: From Biochemical Mechanisms to Clinical Practice (Literature Review).心肌肌钙蛋白代谢：从生化机制到临床实践（文献综述）。
Int J Mol Sci. 2021 Oct 10;22(20):10928. doi: 10.3390/ijms222010928.
10
The manipulation of apoptosis for cancer therapy using BH3-mimetic drugs.使用BH3模拟物药物通过调控细胞凋亡进行癌症治疗
Nat Rev Cancer. 2022 Jan;22(1):45-64. doi: 10.1038/s41568-021-00407-4. Epub 2021 Oct 18.
Zotero 插件